Colin Berry

The index of microcirculatory resistance measured acutely predicts the extent and severity of myocardial infarction in patients with ST-segment elevation myocardial infarction.

Bright-blood T2-weighted MRI has higher diagnostic accuracy than dark-blood short tau inversion recovery MRI for detection of acute myocardial infarction and for assessment of the ischemic area at risk and myocardial salvage.

Myocardial repair and regeneration: bone marrow or cardiac stem cells?

Usefulness of fractional flow reserve to improve diagnostic efficiency in patients with non-ST elevation myocardial infarction.

Microvascular Resistance Predicts Myocardial Salvage and Infarct Characteristics in ST-Elevation Myocardial Infarction.

Prognostic importance of myocardial infarct characteristics.

Prognostic value of the Index of Microcirculatory Resistance measured after primary percutaneous coronary intervention.

Vasodilatory capacity of the coronary microcirculation is preserved in selected patients with non-ST-segment-elevation myocardial infarction.

Fractional flow reserve versus angiography in guiding management to optimize outcomes in non-ST-elevation myocardial infarction (FAMOUS-NSTEMI): rationale and design of a randomized controlled clinical trial.

Multicenter core laboratory comparison of the instantaneous wave-free ratio and resting Pd/Pa with fractional flow reserve: the RESOLVE study.

Cardiac magnetic resonance imaging: the new reference method for infarct characterization and prognostication after myocardial infarction?

A randomized trial of deferred stenting versus immediate stenting to prevent no- or slow-reflow in acute ST-segment elevation myocardial infarction (DEFER-STEMI).

Comprehensive dobutamine stress CMR versus echocardiography in LBBB and suspected coronary artery disease.

LGE and NT-proBNP identify low risk of death or arrhythmic events in patients with primary prevention ICDs.

Adenosine: physiology, pharmacology, and clinical applications.

Fractional flow reserve vs. angiography in guiding management to optimize outcomes in non-ST-segment elevation myocardial infarction: the British Heart Foundation FAMOUS-NSTEMI randomized trial.

Survival in the elderly after acute myocardial infarction: room for more improvement.

Fractional flow reserve-guided management in stable coronary disease and acute myocardial infarction: recent developments.

Assessment of the relationships between myocardial contractility and infarct tissue revealed by serial magnetic resonance imaging in patients with acute myocardial infarction.

Pathophysiology of LV Remodeling in Survivors of STEMI: Inflammation, Remote Myocardium, and Prognosis.

Repeatability of Fractional Flow Reserve Despite Variations in Systemic and Coronary Hemodynamics.

Outcomes of Percutaneous Coronary Intervention Performed at Offsite Versus Onsite Surgical Centers in the United Kingdom.

Physiological assessment of coronary lesion severity: fractional flow reserve versus nonhyperaemic indices.

Assessment of Fractional Flow Reserve in Patients With Recent Non-ST-Segment-Elevation Myocardial Infarction: Comparative Study With 3-T Stress Perfusion Cardiac Magnetic Resonance Imaging.

Prognostic significance of infarct core pathology revealed by quantitative non-contrast in comparison with contrast cardiac magnetic resonance imaging in reperfused ST-elevation myocardial infarction survivors.

Intracoronary Adenosine for Maximal Hyperemia: Less Is More…More or Less?

Safety of guidewire-based measurement of fractional flow reserve and the index of microvascular resistance using intravenous adenosine in patients with acute or recent myocardial infarction.

Fractional flow reserve (FFR) versus angiography in guiding management to optimise outcomes in non-ST segment elevation myocardial infarction (FAMOUS-NSTEMI) developmental trial: cost-effectiveness using a mixed trial- and model-based methods.

Risk stratification in non-ST elevation acute coronary syndromes: Risk scores, biomarkers and clinical judgment.

Myocardial Hemorrhage After Acute Reperfused ST-Segment-Elevation Myocardial Infarction: Relation to Microvascular Obstruction and Prognostic Significance.

The relationship between oxidised LDL, endothelial progenitor cells and coronary endothelial function in patients with CHD.

Temporal Evolution of Myocardial Hemorrhage and Edema in Patients After Acute ST-Segment Elevation Myocardial Infarction: Pathophysiological Insights and Clinical Implications.

Native myocardial longitudinal (T1 ) relaxation time: Regional, age, and sex associations in the healthy adult heart.

New perspectives on the role of cardiac magnetic resonance imaging to evaluate myocardial salvage and myocardial hemorrhage after acute reperfused ST-elevation myocardial infarction.

Urine proteomics in the diagnosis of stable angina.

Continuum of Vasodilator Stress From Rest to Contrast Medium to Adenosine Hyperemia for Fractional Flow Reserve Assessment.

Myocardial strain in healthy adults across a broad age range as revealed by cardiac magnetic resonance imaging at 1.5 and 3.0T: Associations of myocardial strain with myocardial region, age, and sex.

Non-invasive versus invasive management in patients with prior coronary artery bypass surgery with a non-ST segment elevation acute coronary syndrome: study design of the pilot randomised controlled trial and registry (CABG-ACS).

Remote Zone Extracellular Volume and Left Ventricular Remodeling in Survivors of ST-Elevation Myocardial Infarction.

Advances in Magnetic Resonance Imaging of the Myocardial Area at Risk and Salvage.

Infarct size and left ventricular remodelling after preventive percutaneous coronary intervention.

Risk assessment in patients with an acute ST-elevation myocardial infarction.

Microvascular resistance of the culprit coronary artery in acute ST-elevation myocardial infarction.

Comparative Prognostic Utility of Indexes of Microvascular Function Alone or in Combination in Patients With an Acute ST-Segment-Elevation Myocardial Infarction.

Influence of access site choice for cardiac catheterization on risk of adverse neurological events: A systematic review and meta-analysis.

Discordance Between Resting and Hyperemic Indices of Coronary Stenosis Severity: The VERIFY 2 Study (A Comparative Study of Resting Coronary Pressure Gradient, Instantaneous Wave-Free Ratio and Fractional Flow Reserve in an Unselected Population Referred for Invasive Angiography).

The Influence of Lesion Location on the Diagnostic Accuracy of Adenosine-Free Coronary Pressure Wire Measurements.

A Novel Method for Estimating Myocardial Strain: Assessment of Deformation Tracking Against Reference Magnetic Resonance Methods in Healthy Volunteers.

Native T1 mapping: inter-study, inter-observer and inter-center reproducibility in hemodialysis patients.

Validation of the "smart" minimum FFR Algorithm in an unselected all comer population of patients with intermediate coronary stenoses.

Diagnostic Accuracy of 3.0-T Magnetic Resonance T1 and T2 Mapping and T2-Weighted Dark-Blood Imaging for the Infarct-Related Coronary Artery in Non-ST-Segment Elevation Myocardial Infarction.

Fractional flow reserve: a clinical perspective.

How to Mend a Broken Heart?

() Editorial: the Minimalist Immediate Mechanical Intervention study.

Stable Coronary Syndromes: The Case for Consolidating the Nomenclature of Stable Ischemic Heart Disease.

Reference invasive tests of microvascular injury in myocardial infarction.

Meta-Analysis of Death and Myocardial Infarction in the DEFINE-FLAIR and iFR-SWEDEHEART Trials.

Stable coronary syndromes: pathophysiology, diagnostic advances and therapeutic need.

Influence of Contrast Media Dose and Osmolality on the Diagnostic Performance of Contrast Fractional Flow Reserve.

Agreement of the Resting Distal to Aortic Coronary Pressure With the Instantaneous Wave-Free Ratio.

Estimating prognosis in patients with acute myocardial infarction using personalized computational heart models.

Advances in computational modelling for personalised medicine after myocardial infarction.

Persistent Iron Within the Infarct Core After ST-Segment Elevation Myocardial Infarction: Implications for Left Ventricular Remodeling and Health Outcomes.

Persistence of Infarct Zone T2 Hyperintensity at 6 Months After Acute ST-Segment-Elevation Myocardial Infarction: Incidence, Pathophysiology, and Prognostic Implications.

Comparison of Different Diastolic Resting Indexes to iFR: Are They All Equal?

Linking hospital patient records for suspected or established acute coronary syndrome in a complex secondary care system: a proof-of-concept e-registry in National Health Service Scotland.

Arterial Access for Invasive Coronary Angiography: The 'Left Backhander'.

Is Hyperaemia Essential for Accurate Functional Assessment of Coronary Stenosis Severity?

Intravascular ultrasound assessment of the effects of rotational atherectomy in calcified coronary artery lesions.

Coronary microvascular dysfunction in patients with stable coronary artery disease: The CE-MARC 2 coronary physiology sub-study.

Incidence of procedural myocardial infarction and cardiac magnetic resonance imaging-detected myocardial injury following percutaneous coronary intervention with rotational atherectomy.

ISHLT Primary Graft Dysfunction Incidence, Risk Factors, and Outcome: A UK National Study.

Single- Versus 2-Stent Strategies for Coronary Bifurcation Lesions: A Systematic Review and Meta-Analysis of Randomized Trials With Long-Term Follow-up.

Rationale and design of the British Heart Foundation (BHF) Coronary Microvascular Angina (CorMicA) stratified medicine clinical trial.

Magnetic Resonance Perfusion Imaging to Guide Management of Patients With Stable Ischemic Heart Disease.

Hypertension, Microvascular Pathology, and Prognosis After an Acute Myocardial Infarction.

Current Smoking and Prognosis After Acute ST-Segment Elevation Myocardial Infarction: New Pathophysiological Insights.

Sex Differences in Adenosine-Free Coronary Pressure Indexes: A CONTRAST Substudy.

Systemic microvascular dysfunction in microvascular and vasospastic angina.

Prognostic Value of the Residual SYNTAX Score After Functionally Complete Revascularization in ACS.

Society for Cardiovascular Magnetic Resonance (SCMR) expert consensus for CMR imaging endpoints in clinical research: part I - analytical validation and clinical qualification.

Stratified Medical Therapy Using Invasive Coronary Function Testing in Angina: The CorMicA Trial.

Spotlight on Strain Following Myocardial Infarction.

Coronary Thermodilution Waveforms After Acute Reperfused ST-Segment-Elevation Myocardial Infarction: Relation to Microvascular Obstruction and Prognosis.

Circumferential Strain Predicts Major Adverse Cardiovascular Events Following an Acute ST-Segment-Elevation Myocardial Infarction.

Redefining successful primary PCI.

Contrast fractional flow reserve: Attractive alternative to non-hyperaemic pressure ratios for coronary disease evaluation.

Impaired coronary flow reserve: a pre-requisite for coronary revascularization.

Effect of Low-Dose Intracoronary Alteplase During Primary Percutaneous Coronary Intervention on Microvascular Obstruction in Patients With Acute Myocardial Infarction: A Randomized Clinical Trial.

MINOCA: Requirement for Definitive Diagnostic Work-Up.

Rationale and design of the Coronary Microvascular Angina Cardiac Magnetic Resonance Imaging (CorCMR) diagnostic study: the CorMicA CMR sub-study.

Predictive factors of discordance between the instantaneous wave-free ratio and fractional flow reserve.

Is it important to differentiate between peri-procedural myocardial injury and persistent myocardial scar?

Predictors of segmental myocardial functional recovery in patients after an acute ST-Elevation myocardial infarction.

Feature-tracking myocardial strain in healthy adults- a magnetic resonance study at 3.0 tesla.

Mechanical circulatory support for refractory cardiogenic shock post-acute myocardial infarction-a decade of lessons.

Cardiovascular health technology assessment: recommendations to improve the quality of evidence.

Treating Multivessel Coronary Artery Disease in ST-Segment Elevation Myocardial Infarction: Why, How, and When?

Primary graft dysfunction after heart transplantation: a thorn amongst the roses.

The Potential Use of the Index of Microcirculatory Resistance to Guide Stratification of Patients for Adjunctive Therapy in Acute Myocardial Infarction.

Cangrelor versus Ticagrelor in Patients Treated with Primary Percutaneous Coronary Intervention: Impact on Platelet Activity, Myocardial Microvascular Function and Infarct Size: A Randomized Controlled Trial.

Sex-based associations with microvascular injury and outcomes after ST-segment elevation myocardial infarction.

How to Diagnose and Manage Angina Without Obstructive Coronary Artery Disease: Lessons from the British Heart Foundation CorMicA Trial.

Sex differences in procedural and clinical outcomes following rotational atherectomy.

Gaussian process emulation to accelerate parameter estimation in a mechanical model of the left ventricle: a critical step towards clinical end-user relevance.

Optimized Treatment of ST-Elevation Myocardial Infarction.

Cardiac MRI Endpoints in Myocardial Infarction Experimental and Clinical Trials: JACC Scientific Expert Panel.

Diastolic pressure ratio: new approach and validation vs. the instantaneous wave-free ratio.

PREDICTA: A Model to Predict Primary Graft Dysfunction After Adult Heart Transplantation in the United Kingdom.

Healthcare disparities for women hospitalized with myocardial infarction and angina.

Invasive Versus Medical Management in Patients With Prior Coronary Artery Bypass Surgery With a Non-ST Segment Elevation Acute Coronary Syndrome.

'Acute micro-coronary syndrome': detailed coronary physiology in a patient with Takotsubo cardiomyopathy.

Scientific Business Abstracts of the 113th Annual Meeting of the Association of Physicians of Great Britain and Ireland.

1-Year Outcomes of Angina Management Guided by Invasive Coronary Function Testing (CorMicA).

Pathophysiology and diagnosis of coronary microvascular dysfunction in ST-elevation myocardial infarction.

Ischemia and No Obstructive Coronary Artery Disease: Prevalence and Correlates of Coronary Vasomotion Disorders.

Human Microcirculation in Ischemic Heart Disease.

Chronic infarct size after spontaneous coronary artery dissection: implications for pathophysiology and clinical management.

Rationale and design of the British Heart Foundation (BHF) Coronary Microvascular Function and CT Coronary Angiogram (CorCTCA) study.

ISCHEMIA: new questions from a landmark trial.

Genetic dysregulation of endothelin-1 is implicated in coronary microvascular dysfunction.

Effects of Intracoronary Alteplase on Microvascular Function in Acute Myocardial Infarction.

A randomized controlled trial of a physiology-guided percutaneous coronary intervention optimization strategy: Rationale and design of the TARGET FFR study.

Vascular effects of serelaxin in patients with stable coronary artery disease: a randomized placebo-controlled trial.

One-Year Outcomes After Low-Dose Intracoronary Alteplase During Primary Percutaneous Coronary Intervention: The T-TIME Randomized Trial.

Percutaneous coronary intervention versus medical therapy in patients with angina and grey-zone fractional flow reserve values: a randomised clinical trial.

Post-operative myocardial infarction following aortic root surgery with coronary reimplantation: a case series treated with percutaneous coronary intervention.

Coronary microvascular disease: the next frontier for Cardiovascular Research.

Low-Dose Alteplase During Primary Percutaneous Coronary Intervention According to Ischemic Time.

Comparative Significance of Invasive Measures of Microvascular Injury in Acute Myocardial Infarction.

Chest pain without obstructive coronary artery disease: a case series.

Bias and Loss to Follow-Up in Cardiovascular Randomized Trials: A Systematic Review.

Redefining Adverse and Reverse Left Ventricular Remodeling by Cardiovascular Magnetic Resonance Following ST-Segment-Elevation Myocardial Infarction and Their Implications on Long-Term Prognosis.

Displacement Encoding With Stimulated Echoes Enables the Identification of Infarct Transmurality Early Postmyocardial Infarction.

Cardiac Imaging in the Post-ISCHEMIA Trial Era: A Multisociety Viewpoint.

Pooled Analysis of Bleeding, Major Adverse Cardiovascular Events, and All-Cause Mortality in Clinical Trials of Time-Constrained Dual-Antiplatelet Therapy After Percutaneous Coronary Intervention.

Immediate vs Delayed Stenting in ST-Elevation Myocardial Infarction: Rationale and Design of the International PRIMACY Bayesian Randomized Controlled Trial.

Assessment of Vascular Dysfunction in Patients Without Obstructive Coronary Artery Disease: Why, How, and When.

Rationale and design of the Medical Research Council's Precision Medicine with Zibotentan in Microvascular Angina (PRIZE) trial.

Monitoring indirect impact of COVID-19 pandemic on services for cardiovascular diseases in the UK.

Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF).

Apparent growth tensor of left ventricular post myocardial infarction - In human first natural history study.

Effect of coronary flow on intracoronary alteplase: a prespecified analysis from a randomised trial.

Clinical significance of coronavirus disease 2019 in hospitalized patients with myocardial injury.

Percutaneous coronary intervention and 30-day unplanned readmission with chest pain in the United States (Nationwide Readmissions Database).

Risk Stratification Guided by the Index of Microcirculatory Resistance and Left Ventricular End-Diastolic Pressure in Acute Myocardial Infarction.

Predictors of Microvascular Reperfusion After Myocardial Infarction.

Invasive versus medically managed acute coronary syndromes with prior bypass (CABG-ACS): insights into the registry versus randomised trial populations.

Regional variation in cardiovascular magnetic resonance service delivery across the UK.

Outcomes following PCI in CABG candidates during the COVID-19 pandemic: The prospective multicentre UK-ReVasc registry.

What Is the Role of Assessing Ischemia to Optimize Therapy and Outcomes for Patients with Stable Angina and Non-obstructed Coronary Arteries?

Stratified medicine using invasive coronary function testing in angina: A cost-effectiveness analysis of the British Heart Foundation CorMicA trial.

Automated Segmental Analysis of Fully Quantitative Myocardial Blood Flow Maps by First-Pass Perfusion Cardiovascular Magnetic Resonance.

International Prospective Registry of Acute Coronary Syndromes in Patients With COVID-19.

The Health Economics of Ischemia With Nonobstructive Coronary Arteries.

Type 2 myocardial infarction and myocardial injury: eligibility for novel medical therapy to derisk clinical trials.

The role of a comprehensive two-step diagnostic evaluation to unravel the pathophysiology of MINOCA: A review.

Meta-analyses of moving targets.

Cardiovascular Complications Are Uncommon in Healthcare Workers With Mild or Asymptomatic COVID-19 Infection.

Inhibition of myocardial cathepsin-L release during reperfusion following myocardial infarction improves cardiac function and reduces infarct size.

Prevalence of Coronary Artery Disease and Coronary Microvascular Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction.

What an Interventionalist Needs to Know About MI with Non-obstructive Coronary Arteries.

Post-stenting fractional flow reserve vs coronary angiography for optimization of percutaneous coronary intervention (TARGET-FFR).

The Full Revasc (Ffr-gUidance for compLete non-cuLprit REVASCularization) Registry-based randomized clinical trial.

Safety of Selective Intracoronary Hypothermia During Primary Percutaneous Coronary Intervention in Patients With Anterior STEMI.

Strengths and limitations of meta-analyses.

The Future of Cardiac Magnetic Resonance Clinical Trials.

What an Interventionalist Needs to Know About INOCA.

Cardiovascular outcomes of glucose lowering therapy in chronic kidney disease patients: a systematic review with meta-analysis.

Intramyocardial Hemorrhage: The Final Frontier for Preventing Heart Failure Post-Myocardial Infarction.

Is Platelet Reactivity a Therapeutic Target to Limit Microvascular Obstruction?

Coronary Arterial Function and Disease in Women With No Obstructive Coronary Arteries.

Personalizing the Competing Risks for Thrombotic and Bleeding Events in Ischemia With Nonobstructed Coronary Arteries.

CT or Invasive Coronary Angiography in Stable Chest Pain.

A Noncontrast CMR Risk Score for Long-Term Risk Stratification in Reperfused ST-Segment Elevation Myocardial Infarction.